Antiphospholipid antibodies (APLAs) are primarily directed toward phospholipid-binding
proteins and are responsible for thrombotic events. APLAs include anti-β2Glycoprotein I …

Multiple myeloma (MM) is associated with an increased risk of venous and arterial
thrombosis. Pathophysiologic mechanisms include patient, disease and treatment related …

Persistence of serum antiphospholipid antibodies (aPL) is associated with a high thrombotic
risk, both arterial and venous, and with pregnancy complications. Due to the potential …

Hematology represents a dynamic specialty in clinical medicine that requires solid
knowledge of normal and pathological hematopoiesis, cytomorphology, pathology …

Background Despite the significant progress in the treatment of multiple myeloma (MM), the
disease remains untreatable and its cure is still an unmet clinical need. Neoplastic …

Objective The aim of this research was to determine the frequency of antiphospholipid
antibodies (aPL) in patients with COVID-19. Methods The frequency and titers of …

Cancer patients have higher prevalences of antiphospholipid antibodies (aPLs),
occasionally associated with thrombotic events. A cross-sectional study regarding the …

Background and Purpose The development of vaccines against the SARS-CoV-2 virus has
become a big challenge for many countries in 2020-2022. mRNA vaccines were shown to …

Lupus erythematosus is an autoimmune disease that commonly affects the skin, and may
present with cutaneous only disease. This chapter reviews the forms of cutaneous lupus …

Background: Numerous epidemiological research and investigations have been done
discussing the connection between malignancies and antiphospholipid antibodies. Several …